Abbott Molecular Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Abbott Molecular Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6601
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abbott Molecular Inc (Abbott Molecular), formerly Vysis Inc, a subsidiary of Abbott Laboratories, is a medical diagnostics company that provides molecular testing solutions. The company offers infectious disease products, oncology products, genetics products, automation products, molecular diagnostics and assays. It provide PathVysion HER-2 DNA Probe kits, ALK break apart FISH probe kits, and UroVysion bladder cancer kits. Abbott Molecular also offers multi collect specimen collection kits, amplification reagent kits, control kits, HBV application CD-ROM, HBV calibrator and control kits, antifade solutions, CGH hybridization reagents, and FISH pretreatment reagent kits, among others. The company’s therapeutic areas include breast cancer, automation, genetics, infectious disease, and oncology. It has presence in Africa, Asia, Europe, North America, South America and others. Abbott Molecular is headquartered in Des Plaines, Illinois, the US.

Abbott Molecular Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abbott Molecular Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abbott Molecular Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Abbott Molecular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abbott Molecular Inc, Medical Equipment, Deal Details 10
Partnerships 10
Abbott Molecular Enters into Co-Development Agreement with Biocartis 10
Idera Pharma Enters Into Co-Development Agreement With Abbott Molecular For In Vitro Companion Diagnostic Test 11
BioGenex Labs Enters Into Co-Marketing Agreement With Abbott Molecular 12
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 13
BioView Enters Into Agreement With Abbott To Develop Automated Cancer Screening System 14
Abbott Molecular Inc – Key Competitors 15
Abbott Molecular Inc – Key Employees 16
Abbott Molecular Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Abbott Molecular Inc, Medical Equipment, Key Facts 2
Abbott Molecular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abbott Molecular Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abbott Molecular Inc, Deals By Market, 2012 to YTD 2018 8
Abbott Molecular Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abbott Molecular Enters into Co-Development Agreement with Biocartis 10
Idera Pharma Enters Into Co-Development Agreement With Abbott Molecular For In Vitro Companion Diagnostic Test 11
BioGenex Labs Enters Into Co-Marketing Agreement With Abbott Molecular 12
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 13
BioView Enters Into Agreement With Abbott To Develop Automated Cancer Screening System 14
Abbott Molecular Inc, Key Competitors 15
Abbott Molecular Inc, Key Employees 16
Abbott Molecular Inc, Other Locations 17

List of Figures
Abbott Molecular Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Abbott Molecular Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abbott Molecular Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Abbott Molecular Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abbott Molecular Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Abbott Molecular Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shaheen Insurance Company Limited:企業の戦略・SWOT・財務情報
    Shaheen Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Shaheen Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Precision System Science Co Ltd (7707):企業の財務・戦略的SWOT分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company provide products such as automated nucleic acid isolation system, large sample volume nucleic acid extract …
  • Maruhan Corp:企業の戦略・SWOT・財務分析
    Maruhan Corp - Strategy, SWOT and Corporate Finance Report Summary Maruhan Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Baloise Belgium NV:企業の戦略・SWOT・財務分析
    Baloise Belgium NV - Strategy, SWOT and Corporate Finance Report Summary Baloise Belgium NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aushon BioSystems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aushon BioSystems Inc (Aushon) is a medical device provider that provides biomarker measurement and analysis products. The company offers biomarker therapeutic areas in microarray printing technology. It provides products such as ciraplex assay, cirascan imaging and cirasoft analysis and cir …
  • Savannah Petroleum Plc (SAVP):石油・ガス:M&Aディール及び事業提携情報
    Summary Savannah Petroleum Plc (Savannah Petroleum) is an oil and gas company. The company explores, appraises, develops, and produces conventional oil deposits. It operates principal assets in the R1/R2 and R3/R4 PSC areas of the Agadem Rift Basin in South East Niger. Savannah Petroleum blocks cove …
  • Covanta Holding Corporation:企業の戦略・SWOT・財務分析
    Covanta Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary Covanta Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Procurri Corporation Limited (BVQ):企業の財務・戦略的SWOT分析
    Procurri Corporation Limited (BVQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Illinois Municipal Electric Agency:企業の戦略的SWOT分析
    Illinois Municipal Electric Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Taiwan High Speed Rail Corporation:企業の戦略・SWOT・財務分析
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Calithera Biosciences Inc (CALA):企業の財務・戦略的SWOT分析
    Summary Calithera Biosciences Inc (Calithera) is a clinical-stage bio-pharmaceutical company that discovers and develops novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer . The company’s product pipeline includes CB-839, a glutamina …
  • Total SA (FP):石油・ガス:M&Aディール及び事業提携情報
    Summary Total SA (Total) is an integrated global energy company that discovers, produces, refines and markets oil and gas, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distributio …
  • Medicure Inc (MPH):企業の財務・戦略的SWOT分析
    Summary Medicure Inc (Medicure) is a pharmaceutical company that strives to research, develop and commercialize therapeutics for cardiovascular diseases. The company offers products such as Aggrastat, a glycoprotein GP IIb/IIIa receptor antagonist indicated for the treatment of acute coronary syndro …
  • Composites Technology Research Malaysia Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Astronics Corp:企業の戦略・SWOT・財務情報
    Astronics Corp - Strategy, SWOT and Corporate Finance Report Summary Astronics Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tokyo Electric Power Company Holdings Incorporated:発電所・企業SWOT分析
    Tokyo Electric Power Company Holdings Incorporated – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysi …
  • Sopharma AD (3JR):企業の財務・戦略的SWOT分析
    Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Caleres Inc (CAL):企業の財務・戦略的SWOT分析
    Caleres Inc (CAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Gap, Inc.:企業の戦略・SWOT・財務情報
    The Gap, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Gap, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆